Company lists
The Massachusetts edition · 2026

Life sciencescompanies in Massachusetts

Oncology, research tools, genomics, therapeutics, startups and more: the companies building life sciences in Massachusetts, with their founders, funding, team size and business models.

1,749 company profiles749 with recorded fundingNovember 2026 edition
Massachusetts · Photo: Wikimedia Commons (CC BY-SA 4.0)

Recent life sciences business events in Massachusetts

Funding, M&A, contract wins and launches involving 2,561 life sciences companies in Massachusetts, last 24 months: 246 M&A deals · 239 funding rounds · 79 Contracts · 7 launches. Newest first; companies and investors link to their Fliar profiles. Latest event in our news feed: Jun 2026.

ContractService

Stellantis · client: Evera

With this agreement, Evera aims to rent 2,000 electric vehicles reconditioned by the Stellantis group by the end of 2027.

FundingNon-dilutive Capital

Apogee therapeutics

Apogee Therapeutics secured up to $1.3 billion in flexible, non-dilutive capital last month from Blackstone Life Sciences, including up to $800 million in synthetic royalty and access to…

Investors Blackstone Life Sciences
Biotech
FundingPublic Offering

Editas medicine

In second place, gene editing company Editas Medicine announced a public offering of up to $319.4 million.

Investors Na
Biotech
ContractTechnology

Oscotec · client: Agios pharmaceuticals

Under the terms of the agreement, Agios will obtain exclusive global rights to develop and commercialize cevidoplenib across all indications and will assume full responsibility for…

Pharmaceutical
M&AAcquisition · Completed

Kanders & Company acquires Ginkgo bioworks

A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks.

Biosecurity
M&AAcquisition · Announced

Veeva systems acquires Yonalink

US cloud software systems provider for the life sciences industry Veeva Systems (NYSE: VEEV), which has a market cap of $26 billion, has acquired Israeli clinical trial and data…

Clinical trial and data streaming
M&AMerger · Announced

Pulmatrix acquires Eos SENOLYTIX

On March 26, 2026, Pulmatrix entered into a definitive merger agreement with privately held Eos SENOLYTIX, a biotechnology company focused on gerotherapeutic peptides for aging-related…

Biotechnology
M&AAcquisition · Announced

Foundation medicine acquires Saga diagnostics

And with the $595 million acquisition of Saga Diagnostics announced last month, Roche subsidiary Foundation Medicine will gain a new tool in the disease monitoring market with the firm's…

Diagnostics
M&AAcquisition · Announced

Eli Lilly and Company acquires Kelonia therapeutics

Eli Lilly and Company announced the acquisition of Kelonia Therapeutics, Inc., a biotechnology company focused on oncology drug development, for a consideration of up to $7 billion.

Biotechnology
FundingEquipment financing

Torus

Trinity Capital Inc. (Nasdaq: TRIN) ... commitment of up to $35 million in equipment financing to Torus.

Investors Trinity capital
Energy Technology
M&AAcquisition · Announced

Eli Lilly and Company acquires Ajax therapeutics

Eli Lilly and Company (NYSE: LLY) has agreed to acquire Ajax Therapeutics, Inc. in a cash deal worth up to $2.3 billion, including upfront and milestone-linked payments, to add a…

Biotech
ContractService

Salesforce’s Agentforce Life Sciences · client: Moderna

Tuesday, April 28, 2026 – Salesforce today announced that Moderna has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to unify the biotechnology company’s global…

Life Sciences
ContractTechnology

Salesforce · client: Moderna

Salesforce today announced that Moderna has selected Salesforce’s Agentforce Life Sciences for Customer Engagement to unify the biotechnology company’s global commercial operations.

Life Sciences
M&AAcquisition · Announced

XRF Scientific acquires Bruker

XRF Scientific (ASX: XRF) is acquiring Bruker AXS SE’s Combustion Gas Analysis (CGA) business for USD 4.0 million upfront, expanding its product portfolio and bringing manufacturing to…

ContractSupply

Caelux · client: Solx

The Solx-Caelux deal specifies 3 GW of hybrid modules over five years.

Solar Technology
M&AAcquisition · Announced

Kelonia acquires Therapeutics

The announcement of the Kelonia-Therapeutics acquisition on Monday kicked off: up to 7 billion dollars in total, of which 3.25 billion dollars are due immediately.

M&AAcquisition · Announced

Eli lilly acquires Kelonia therapeutics

Eli Lilly has entered a definitive agreement to acquire Kelonia Therapeutics for up to $7 billion.

Biotech
M&AAcquisition · Announced

Collegium pharmaceutical acquires AZSTARYS

Collegium is acquiring AZSTARYS, related intellectual property, and global rights from Corium, a private company, for $650 million upfront.

Pharmaceutical
M&AMerger · Announced

Obsidian therapeutics acquires Galera therapeutics

RTW Biotech Opportunities Ltd, a London-listed investment company focused on the life sciences sector, said Tuesday that portfolio company Obsidian Therapeutics Inc. has agreed to merge…

Life sciences
M&AAcquisition · Announced

Humanly acquires Anthill

Bellevue, Wash.-based Humanly, a startup that makes AI-powered interviewing tools for employers, announced it has acquired Anthill, a platform that uses AI to help companies connect with…

Human Resources
M&AAcquisition · Announced

Algert global acquires Praxis precision medicines

Algert Global LLC boosted its holdings in shares of Praxis Precision Medicines by 483.3% in the 3rd quarter.

Biopharmaceutical
M&AAcquisition · Announced

Allspring global investments acquires Praxis precision medicines

Allspring Global Investments Holdings LLC bought a new stake in Praxis Precision Medicines, Inc. during the fourth quarter, according to the company in its most recent disclosure with…

Biopharmaceutical
M&AAcquisition · Announced

Deerfield Management Company L.P. acquires Praxis precision medicines

Deerfield Management Company L.P. boosted its holdings in shares of Praxis Precision Medicines by 22.4% in the 3rd quarter.

Biopharmaceutical
M&AAcquisition · Announced

Readystate Asset Management LP acquires Praxis precision medicines

Readystate Asset Management LP acquired a new stake in shares of Praxis Precision Medicines in the 3rd quarter valued at $5,786,000.

Biopharmaceutical
M&AAcquisition · Announced

Adage Capital Partners GP L.L.C. acquires Praxis precision medicines

Adage Capital Partners GP L.L.C. boosted its holdings in shares of Praxis Precision Medicines by 13.3% in the 2nd quarter.

Biopharmaceutical
FundingPIPE

Korro bio

Korro Bio raised $85 million from a PIPE financing.

Investors Na
RNA Editing – Metabolic Disorders
FundingPrivate Placement

Solid biosciences

Solid Biosciences ... bringing in $240 million from a private placement.

Investors Na
Gene Therapy – Rare Neuromuscular and Cardiac Diseases
FundingSeries D

Life biosciences

Life Biosciences (Boston), a biotech focused on therapies to reverse cellular aging, announced an $80 million Series D round to fund a cellular rejuvenation platform.

Investors Not publicly disclosed
Biotech
Funding

Transcode therapeutics

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, today announced that it has…

Investors Institutional healthcare investor
Immuno-oncology, RNA therapeutics

Life sciences companies in Massachusetts, by funding and team

Few life sciences companies in Massachusetts publish revenue, so this list compares what is on record instead: recorded equity funding, team size, revenue model, age and stage. The 50 companies below lead on recorded funding and team size among 1,749 active companies.

Showing 25 of 50

Developer of mRNA-based therapeutics for a wide range of diseases

Gene therapy
US$2.78bnSeries G · May 2018
6,184+59% 12 mo to Dec 2022LinkedIn · Oct 2026
E-commerce - product / Physical commerce
16 yr2010
0none in 3 months · last posted Jun 2026

Provider of osmotic pump for subcutaneous drug delivery

Drug delivery
US$1.89bnSeries J · Jan 2020
68-99% 12 mo to Dec 2022LinkedIn · Oct 2026
Fee-for-service
31 yr1995
0none in 3 months

Provider of transnational research for portfolio of cell and gene therapy

Genomics
US$1.25bnSeries D · May 2023
441-11% vs previous recordLinkedIn · Oct 2026
Fee-for-service
8 yr2018
0none in 3 months · last posted Mar 2026

Developer of therapies for treating obesity and related conditions

Obesity
US$1.00bnSeries B · Oct 2025
185LinkedIn · Oct 2026
E-commerce - product / Physical commerce
2 yr2024
0none in 3 months · last posted Jun 2026

Autonomous labs for biotechnology, empowering scientists to design the living world

Genomics
US$795.75mSeries E · May 2020
487-6% 12 mo to Dec 2023LinkedIn · Oct 2026
Subscription
18 yr2008
0none in 3 months · last posted Mar 2026

AI-based drug research and development company

Generative ai
US$784.80mSeries D · Aug 2021
397LinkedIn · Oct 2026
Subscription
12 yr2014
0none in 3 months · last posted Nov 2025

Developer of immunotherapeutics for immunological and cancer diseases

Immunotherapy
US$717.24mSeries D · Jun 2025
127+116% 12 mo to Dec 2022LinkedIn · Oct 2026
Physical commerce
8 yr2018
0none in 3 months

Developer of a platform for generating novel protein-based therapeutic modalities

Immunology
US$693.00mSeries C · Dec 2024
329-67% vs previous recordLinkedIn · Oct 2026
Subscription
8 yr2018
0none in 3 months · last posted Apr 2026

Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases

Immunology
US$637.00mSeries F · Sep 2023
99+40% 12 mo to Dec 2022LinkedIn · Jul 2026
E-commerce - product / Physical commerce
17 yr2009
0none in 3 months

Developer of precision medicines for neuropsychiatric disorders and neurodegenerative disorders

Neurology
US$612.00mSeries B · Oct 2022
96+2% vs previous recordLinkedIn · Oct 2026
Physical commerce
6 yr2020
0none in 3 months · last posted Jan 2026

Provider of new genome engineering technology for treating multiple diseases

Life sciences platforms and tools
US$610.00mSeries C · Apr 2022
202LinkedIn · Jul 2026
Subscription
9 yr2017
0none in 3 months

Developer of AI-powered autonomous scientific research platforms

Life sciences tech
US$550.00mSeries A · Oct 2025
—Not available
Subscription
3 yr2023
0none in 3 months · last posted Jun 2026

Developer of cell-penetrating mini-proteins to target intracellular disease drivers

Oncology
US$530.90mSeries E · Mar 2024
212+33% 12 mo to Dec 2021LinkedIn · Oct 2026
E-commerce - product / Physical commerce
11 yr2015
0none in 3 months · last posted Mar 2026

Developer of drug discovery platform and study protein motion

Life sciences tech
US$520.00mSeries C · Dec 2018
225+66% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
10 yr2016
0none in 3 months · last posted Mar 2026

AI-enabled bioinformatics platform for drug discovery and biomarker development

Life sciences tech
US$509.76mSeries E · Jan 2025
288LinkedIn · Oct 2026
Fee-for-service
12 yr2014
0none in 3 months

Proton therapy systems for oncology

Oncology
US$500.18mSeries F · Jun 2018
247-3% 12 mo to Dec 2021LinkedIn · Jul 2026
Physical commerce
22 yr2004
0none in 3 months · last posted Jul 2026

Diabetes monitoring and management systems

Diabetes
US$500.00mPE · Sep 2016
—Not available
Fee-for-service
10 yr2016
—No postings tracked

Developer of a gene transplantation platform for humanizing pig cells

Genomics
US$481.42mSeries D · Sep 2024
153+52% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months · last posted Feb 2026

Mobile health platform for doctors to manage clinical trials

Life sciences tech
US$477.62mSeries D · Apr 2022
78+61% 12 mo to Dec 2020LinkedIn · Oct 2026
Subscription
14 yr2012
0none in 3 months

Developer of antibodies for the treatment of SARS-CoV-2

Infectious diseases
US$466.00mSeries C · Apr 2021
187-32% vs previous recordLinkedIn · Oct 2026
Physical commerce
6 yr2020
0none in 3 months · last posted Jul 2026

Developer of miniaturized MRI platforms for clinical diagnostics

Infectious diseases
US$454.30mSeries E · Mar 2013
54+28% 12 mo to Dec 2022LinkedIn · Oct 2026
Subscription
20 yr2006
0none in 3 months

Developer of immune-modulatory bio-therapeutics for autoimmune diseases and cancer

Immunology
US$451.77mSeries C · Feb 2025
40+100% 12 mo to Dec 2022LinkedIn · Jul 2026
Subscription
11 yr2015
0none in 3 months

Developer of drugs for the treatment of cancer

Oncology
US$450.00mSeries C · May 2025
16+88% 12 mo to Dec 2021LinkedIn · Oct 2026
Physical commerce / Subscription
6 yr2020
0none in 3 months

Developer of RNA therapeutics

Diversified pharmaceuticals
US$440.00mSeries B · Aug 2021
43-47% vs previous recordLinkedIn · Oct 2026
E-commerce - product / Physical commerce
9 yr2017
—No postings tracked

Developer of a medical device for the treatment of Alzheimer's disease

Neurology
US$420.27mSeries C · Mar 2026
65+0% vs previous recordLinkedIn · Jul 2026
Fee-for-service
10 yr2016
0none in 3 months · last posted Jan 2026
50 of 1,749 companies shown here · the full list is on Radar
Fliar Radar

Explore all 1,749 life sciences companies in Massachusetts on Radar

This page shows the top 50. Radar has the complete, filterable list with contacts and live company signals.

Open life sciences in Massachusetts on Radar
  • Every company, not just 50All 1,749 life sciences companies in Massachusetts, filterable by stage, funding, team size, revenue model and age.
  • Founders and decision-makersLeadership teams with roles and verified LinkedIn profiles, ready for outreach.
  • Live signalsFunding rounds, hiring, launches and M&A as they happen, with alerts on the companies you follow.
  • Save and exportBuild lists, compare companies side by side and export them from your Radar account.

Explore life sciences companies in Massachusetts by what you are looking for

Discover top life sciences companies in Massachusetts across oncology, genomics, research tools, and therapeutics. Compare life sciences startups in Massachusetts by their scientific focus.

7 ways to explore life sciences in Massachusetts

Oncology & cancer therapeutics companiesLife science tools & research platform companiesGenomics & gene therapy companiesNeurology, rare disease & therapeutic companiesLife sciences startups in MassachusettsLife sciences companies hiring in Massachusetts

Oncology & cancer therapeutics companies

Life sciences companies developing cancer drugs, diagnostics, and immunotherapies.

  1. Moderna

    Developer of mRNA-based therapeutics for a wide range of diseases

    Gene therapy
    See in list
  2. Odyssey

    Developer of immunotherapeutics for immunological and cancer diseases

    Immunotherapy
    See in list
  3. Generate Biomedicines

    Developer of a platform for generating novel protein-based therapeutic modalities

    Immunology
    See in list
  4. Nimbus Therapeutics

    Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases

    Immunology
    See in list
  5. Fog Pharmaceuticals

    Developer of cell-penetrating mini-proteins to target intracellular disease drivers

    Oncology
    See in list

Life science tools & research platform companies

Providers of instruments, platforms, assays, and research technology.

  1. XtalPi

    AI-based drug research and development company

    Generative ai
    See in list
  2. Tessera Therapeutics

    Provider of new genome engineering technology for treating multiple diseases

    Life sciences platforms and tools
    See in list
  3. Lila Sciences

    Developer of AI-powered autonomous scientific research platforms

    Life sciences tech
    See in list
  4. Relay Therapeutics

    Developer of drug discovery platform and study protein motion

    Life sciences tech
    See in list
  5. In Silico

    AI-enabled bioinformatics platform for drug discovery and biomarker development

    Life sciences tech
    See in list

Genomics & gene therapy companies

Companies applying genomics, clinical sequencing, and gene therapy.

  1. ElevateBio

    Provider of transnational research for portfolio of cell and gene therapy

    Genomics
    See in list
  2. Ginkgo Bioworks

    Autonomous labs for biotechnology, empowering scientists to design the living world

    Genomics
    See in list
  3. Tessera Therapeutics

    Provider of new genome engineering technology for treating multiple diseases

    Life sciences platforms and tools
    See in list
  4. eGenesis

    Developer of a gene transplantation platform for humanizing pig cells

    Genomics
    See in list
  5. Prime Medicine

    Developer of genetic therapies for a wide range of diseases

    Genomics
    See in list

Neurology, rare disease & therapeutic companies

Drug developers focused on neurological, rare, and infectious diseases.

  1. Generate Biomedicines

    Developer of a platform for generating novel protein-based therapeutic modalities

    Immunology
    See in list
  2. Adagio

    Developer of antibodies for the treatment of SARS-CoV-2

    Infectious diseases
    See in list
  3. Cognito Therapeutics

    Developer of a medical device for the treatment of Alzheimer's disease

    Neurology
    See in list
  4. Atea

    Developer of therapeutics for viral diseases

    Infectious diseases
    See in list
  5. binx health

    Developer of a diagnostic platform for sexually transmitted infections

    Infectious diseases

Life sciences startups in Massachusetts

Recently founded life sciences companies in Massachusetts.

  1. Kailera

    Developer of therapies for treating obesity and related conditions

    Obesity
    See in list
  2. Lila Sciences

    Developer of AI-powered autonomous scientific research platforms

    Life sciences tech
    See in list
  3. Upstream Bio

    Developer of therapeutics for allergic and inflammatory diseases

    Immunology
    See in list
  4. AvenCell

    Developer of next-generation switchable CAR T-cell immunotherapies

    Immunotherapy
    See in list
  5. Aktis Oncology

    Developer of radiopharmaceuticals for solid tumor cancers

    Oncology
    See in list
246 companies in Massachusetts

Life sciences companies hiring in Massachusetts

Life sciences companies in Massachusetts with hiring activity.

  1. Moderna

    Developer of mRNA-based therapeutics for a wide range of diseases

    Gene therapy
    See in list
  2. ElevateBio

    Provider of transnational research for portfolio of cell and gene therapy

    Genomics
    See in list
  3. Kailera

    Developer of therapies for treating obesity and related conditions

    Obesity
    See in list
  4. Ginkgo Bioworks

    Autonomous labs for biotechnology, empowering scientists to design the living world

    Genomics
    See in list
  5. XtalPi

    AI-based drug research and development company

    Generative ai
    See in list
50 companies in Massachusetts

Public life sciences companies in Massachusetts

Publicly listed life sciences companies in Massachusetts.

  1. Moderna

    Developer of mRNA-based therapeutics for a wide range of diseases

    Gene therapy
    See in list
  2. Kailera

    Developer of therapies for treating obesity and related conditions

    Obesity
    See in list
  3. Ginkgo Bioworks

    Autonomous labs for biotechnology, empowering scientists to design the living world

    Genomics
    See in list
  4. XtalPi

    AI-based drug research and development company

    Generative ai
    See in list
  5. Odyssey

    Developer of immunotherapeutics for immunological and cancer diseases

    Immunotherapy
    See in list
156 companies in Massachusetts
Mobile reach

Top 10 life sciences apps from Massachusetts

The most-installed Android apps published by life sciences companies headquartered in Massachusetts — 381K installs between them. 20 companies on this page publish at least one app; each company (legal entity) appears once, with its most-installed app.

1 of 10
1

Omnipod 5

by Omnipod

Installs116K
Rating2.61K ratings
Last updatedMay 2026
Omnipod 5 screenshot 1Omnipod 5 screenshot 2Omnipod 5 screenshot 3Omnipod 5 screenshot 4Omnipod 5 screenshot 5Omnipod 5 screenshot 6
2
Installs99K
Rating3.25220 ratings
Last updatedMay 2026
Rayyan screenshot 1Rayyan screenshot 2Rayyan screenshot 3Rayyan screenshot 4Rayyan screenshot 5Rayyan screenshot 6
3

Allurion

by Allurion

Installs95K
Rating4.751K ratings
Last updatedMay 2026
Allurion screenshot 1Allurion screenshot 2Allurion screenshot 3Allurion screenshot 4Allurion screenshot 5Allurion screenshot 6
4

Care+ CZ

by Biogen

Installs22K
Rating—
Last updatedAug 2025
Care+ CZ screenshot 1Care+ CZ screenshot 2Care+ CZ screenshot 3Care+ CZ screenshot 4Care+ CZ screenshot 5Care+ CZ screenshot 6
5

iLet App

by Beta Bionics

Installs20K
Rating4.21105 ratings
Last updatedAug 2025
iLet App screenshot 1iLet App screenshot 2iLet App screenshot 3iLet App screenshot 4iLet App screenshot 5iLet App screenshot 6
6

Form Health

by Form Health

Installs18K
Rating2.39104 ratings
Last updatedJun 2026
Form Health screenshot 1Form Health screenshot 2Form Health screenshot 3Form Health screenshot 4
7

miniPCR v2

by miniPCR

Installs8K
Rating4.825 ratings
Last updatedMar 2019
miniPCR v2 screenshot 1miniPCR v2 screenshot 2miniPCR v2 screenshot 3miniPCR v2 screenshot 4miniPCR v2 screenshot 5miniPCR v2 screenshot 6
8

MX908 Remote (3.3+)

by 908 Devices

Installs994
Rating—
Last updatedJul 2025
MX908 Remote (3.3+) screenshot 1MX908 Remote (3.3+) screenshot 2MX908 Remote (3.3+) screenshot 3MX908 Remote (3.3+) screenshot 4
9

Kneuro

by BrainRobotics

Installs947
Rating—
Last updatedFeb 2026
Kneuro screenshot 1Kneuro screenshot 2Kneuro screenshot 3Kneuro screenshot 4
Installs515
Rating—
Last updatedMay 2026
stWear screenshot 1stWear screenshot 2stWear screenshot 3
RadarBrowse every life sciences company in Massachusetts on RadarOpen the full list and use the App Downloads and App Growth filters to keep only companies with a mobile app. This rail shows only the ten most-installed.Browse on Radar
For investors and data teams

Put this intelligence into your own tools

The figures on this page come from Fliar’s company, funding, hiring and news data. Use it through the Investor Intelligence API and company data exports, or explore every company, founder and investor in Radar.

Capital & corporate activity

Life sciences funding and M&A across the United States

22,455 recorded equity rounds have gone to 27,407 life sciences companies in the United States — how much, at which stage, into which sub-sectors, from whom, and how Massachusetts compares. Debt, IPO and grant rounds are excluded.

equity rounds, last 12 months360

US$13.54bn

equity rounds, last 24 months1232

US$37.38bn

raised over five yearsUS$157.58bn

5,603 rounds in the United States

M&A deals, Massachusetts246

last 24 months

Capital by year

Equity funding into life sciences in the United States

amount rounds
$26bn20181450
$23bn20191352
$32bn20201398
$45bn20211383
$30bn20221075
$22bn20231064
$25bn2024940
$23bn2025850
$12bn2026291

Bars show US$ raised; the number under each year is equity rounds. 2026 is year to date. The peak year was 2021, with US$45.29bn across 1383 rounds.

The funding ladder · five years

Rounds and typical cheque by stage

AngelUS$70.78m18 rounds · median US$1.40m
SeedUS$5.87bn1,808 rounds · median US$1.11m
Series AUS$38.68bn1,753 rounds · median US$8.80m
Series BUS$46.06bn1,089 rounds · median US$23.00m
Series CUS$30.98bn517 rounds · median US$42.00m
Series D+US$35.59bn392 rounds · median US$50.00m
Private equityUS$66.54m22 rounds · median US$14.25m
Where the money went · five years

Most-funded sub-sectors

OncologyUS$24.87bn658 rounds · 368 companies
Life sciences techUS$16.70bn556 rounds · 344 companies
GenomicsUS$15.90bn409 rounds · 249 companies
NeurologyUS$13.39bn445 rounds · 248 companies
ImmunologyUS$12.90bn189 rounds · 111 companies
Life sciences platforms and toolsUS$7.97bn387 rounds · 238 companies
Cardiac and vascular disordersUS$7.63bn313 rounds · 172 companies
Corporate activity · last 24 months

M&A in Massachusetts

197Acquisition
42Merger
4Takeover

Most active acquirers

  1. Eli lilly10
  2. Waters corporation10
  3. Carlyle Group, SK Capital Partners7
  4. Sanofi6
  5. Lantheus holdings6

Most acquired or merged

  1. Bluebird bio14
  2. Praxis precision medicines6
  3. Inozyme pharma4
  4. Syndax pharmaceuticals4
  5. Astria therapeutics3

Each deal appears in the events strip at the top of the page.

Go deeper in the life sciences landscape reports:

Life Sciences Industry Landscape of the United States
Industry landscape report

Life Sciences Industry Landscape of the United States

The financials above are one chapter. The full life sciences landscape of Massachusetts maps the whole industry — every segment, the capital behind it, the talent market and where the next opportunities are.

  • Market map of every sub-sector
  • Funding & company formation by year
  • Revenue, profit & financial strength
  • Digital footprint: traffic, apps, releases
  • Hiring, skills & pay
  • Founders & leaders
  • News & sentiment
  • Where demand runs ahead of supply
Read the life sciences landscape of Massachusetts

Life sciences funding in Massachusetts

749 life sciences companies in Massachusetts have recorded equity funding, US$68.67bn in total. Totals and round dates describe the historical record; they are not current valuations.

Founders and momentum in Massachusetts

Meet the people behind life sciences companies in Massachusetts. 1,256 of 1,749 companies list founders or leaders; where a public LinkedIn profile matches exactly, the expanded profile shows the photo, headline, location and education.

Explore Massachusetts life sciences companies by sub-sector

The most common specialisations among life sciences companies in Massachusetts. Open a company to see what it sells, who runs it and how far it has come.

Keep exploring life sciences in the United States and nearby markets.

Company lists

Company listLife Sciences Companies in Atlanta, United States133 companiesCompany listLife Sciences Companies in Austin, United States221 companiesCompany listLife Sciences Companies in Boston, United States537 companiesCompany listLife Sciences Companies in Chicago, United States205 companiesCompany listLife Sciences Companies in Dallas, United States104 companiesCompany listLife Sciences Companies in Denver, United States82 companiesCompany listEnterprise Applications Companies in Massachusetts, United States2,090 companiesCompany listBusiness Services Companies in Massachusetts, United States1,862 companiesCompany listHealthTech Companies in Massachusetts, United States1,296 companiesCompany listHealthcare Companies in Massachusetts, United States1,192 companiesCompany listConsumer Companies in Massachusetts, United States1,181 companiesCompany listHigh Tech Companies in Massachusetts, United States1,096 companiesCompany listInvestment Industry Companies in Massachusetts, United States1,007 companiesCompany listRetail Companies in Massachusetts, United States811 companies

Explore more lists: nearby cities and other sectors in Massachusetts

254 more company lists you can search, plus the Radar directory pages for each place.

Life sciences in nearby cities

Life sciences in other US cities

Other sectors in Massachusetts

Browse the Radar directory

Coming soon